Category: Pharmacy - Page 3

IVIVC lets generic drug makers replace costly human bioequivalence trials with lab-based dissolution testing. Learn how it works, why most submissions fail, and which drugs benefit most.

Generic drugs saved the U.S. healthcare system $467 billion in 2024 and $3.4 trillion over the past decade. They make up 90% of prescriptions but only 12% of drug spending, proving affordability doesn’t mean compromise.

Learn the difference between predictable and unpredictable drug side effects, why they matter for safety, and how genetics and dosing impact your risk. Understand what to watch for and how to protect yourself.

OTC sleep aids may seem harmless, but they come with real risks like dizziness, memory problems, and increased dementia risk. Learn what's really in them, how long you should use them, and safer alternatives that actually work.

Biosimilars are not exact copies of biologics - tiny manufacturing differences can affect how your immune system responds. Learn why immunogenicity varies and what it means for patients.

Tacrolimus neurotoxicity causes tremor, headache, and other neurological symptoms in up to 40% of transplant patients-even when blood levels are normal. Learn what triggers it, how to manage it, and what to ask your care team.

Combining H2 blockers and PPIs for acid reflux is common-but often unnecessary and risky. Learn why most people don't need both, what side effects to watch for, and how to safely reduce or stop these medications.

Hydrophilic and lipophilic statins differ in how they move through the body, affecting side effect risks like muscle pain. Learn which statins are linked to fewer problems and how to choose based on your health profile.

State laws on generic drug substitution vary widely across the U.S., affecting how pharmacists swap brand-name drugs for cheaper generics. Learn how rules differ by state, what drugs are restricted, and what this means for your health and costs.

Biosimilars are billed differently than generics under Medicare Part B. Learn how HCPCS codes, the 6% add-on, and the JZ modifier affect reimbursement - and why providers may still choose brand-name biologics.